KZA - Kazia Therapeutics

[tinhat]

Stick 'em up, give me all your money. lol.
Hope you are keeping an eye on it tinhat, that gap looks like it needs closing.
Good one for you.

View attachment 114887

I don't plan to die any time soon but I will die poor.

I've benefited from a few technical analysts who have corrected me on my technical reading of charts. I'm not a T/A. I buy and hold on fundamentals but time entry/exit and dabble around at my exposure based on my crude T/A skills.

'enclyclopedia of chart patterns', Bulkowski (2013, Second edition), p362 states:

"Bull market gaps do well when they appear near the yearly high. Large gaps perform better than small ones."

While Bulowski finds that most breakout gaps (66%) close after one year, my observation of the KZA chart posted above shows that this does not imply that gaps signal any break to a long term uptrend.

I do use gaps and retracement levels as potential entry and top-up (trend reversal) levels.

 

[tinhat]

I've chosen KZA for the December 2020 stock picking comp. I've said everything I can say about this stock here over some time now. It is my largest holding. I'm hoping that this drug will become all that it has the potential to be. It's retraced almost 50% from its recent run up. The market expects there to be some more news regarding drug trials before Christmas.

 

[tinhat]

Well, bit of a retrace going on. It's all good. Mungo MacAllum. Bless his socks. There you go. There's no point trying to steel from others if you want to have a go of things.

 

[tinhat]

Censors are going to get me Mungo!

 

[tinhat]

Mungo. Rest your bones.

 

[Miner]

There were not much notes on this thread.
KZA has slumped by 47% after a mild positive report announced today .
The outcome did not meet the pre defined criteria was the underlined message

https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02548352-5AKES9M2PL78UELCEB65765UAR/pdf?access_token=0007dW0mjTTVK8ruVpc5TXGOIFW5

 

[noirua]

Kazia Therapeutics' (ASX:KZA) paxalisib shows positive signals against preclinical melanoma models

Kazia Therapeutics' (ASX:KZA) paxalisib brain cancer drug has demonstrated positive efficacy signals against a range of preclinical models of metastatic melanoma.

themarketherald.com.au

Kazia Therapeutics’ (KZA) paxalisib brain cancer drug has demonstrated positive efficacy signals against a range of preclinical models of metastatic melanoma.

The study showed paxalisib to be active in vitro and in vivo with data suggesting substantial activity for paxalisib as a monotherapy and greater activity in combination with MEK and BRAF inhibitors.